JAML and neoplasm: As expected, compared with the shNC or vector group, JAML knockdown significantly inhibited the xenograft tumor growth of A549 cells (Fig. 5c), and overexpression of JAML promoted the xenograft tumor growth of PC9 cells (Fig. 5d).